Seeing Is Believing
Currently out of the existing stock ratings of Catherine Ramsey Schulte, 98 are a BUY (82.35%), 21 are a HOLD (17.65%).
Analyst Catherine Ramsey Schulte, currently employed at BAIRD, carries an average stock price target met ratio of 70.25% that have a potential upside of 24.52% achieved within 121 days.
Catherine Ramsey Schulte’s has documented 246 price targets and ratings displayed on 10 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TMO, Thermo Fisher Scientific at 24-Jul-2025.
Analyst best performing recommendations are on MRVI (MARAVAI LIFESCIENCES HOLDINGS ).
The best stock recommendation documented was for ILMN (ILLUMINA) at 9/22/2020. The price target of $281 was fulfilled within 3 days with a profit of $19.8 (7.58%) receiving and performance score of 25.27.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$150
$8.36 (5.90%)
$125
5 days ago
(01-Oct-2025)
14/16 (87.5%)
$11.3 (8.15%)
120
Buy
$150
$8.36 (5.90%)
$116
22 days ago
(14-Sep-2025)
15/20 (75%)
$24.37 (19.40%)
365
Hold
$130
$-11.64 (-8.22%)
$145
2 months 29 days ago
(07-Jul-2025)
5/5 (100%)
$8.99 (7.43%)
43
Buy
$155
$13.36 (9.43%)
$165
4 months 8 days ago
(28-May-2025)
7/10 (70%)
$41.96 (37.12%)
278
Hold
$150
$8.36 (5.90%)
$147
9 months 24 days ago
(12-Dec-2024)
8/8 (100%)
$11.84 (8.57%)
98
Which stock is Catherine Ramsey Schulte is most bullish on?
What Year was the first public recommendation made by Catherine Ramsey Schulte?